Screener
VolitionRX Limited VNRX Q1 2025 Annual earnings
Reported May 15, 2025 · After market close
Revenue$246.4KMiss by $837.6K
EPS-$0.06In line
Revenue estimate$1.1M
EPS estimate-$0.06
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$706.4K
EPS estimate-$0.38
Versus estimates
Revenue
Diluted EPS
FAQ
- When did VolitionRX Limited report Q1 2025 earnings?
- VolitionRX Limited (VNRX) reported Q1 2025 earnings on May 15, 2025 after market close.
- What were VolitionRX Limited's Q1 2025 revenue and EPS?
- VolitionRX Limited reported revenue of $246.4K and eps of $-0.06 for Q1 2025.
- Did VolitionRX Limited beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.1M by $837.6K. EPS beat the consensus estimate of $-0.06 by $0.00.
- How did VolitionRX Limited's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.6% from $171.5K a year earlier and eps grew 40.0% from $-0.10.
- Where can I find VolitionRX Limited's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001477932-25-003852) and the 10-K periodic report (0001477932-25-002231) directly on SEC EDGAR. The filing index links above go to sec.gov.
